Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Intangibles (2020 - 2025)

Historic Intangibles for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to $296.8 billion.

  • Universe Pharmaceuticals' Intangibles rose 1289.84% to $296.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $296.8 billion, marking a year-over-year increase of 1289.84%. This contributed to the annual value of $296.8 billion for FY2025, which is 1289.84% up from last year.
  • Latest data reveals that Universe Pharmaceuticals reported Intangibles of $296.8 billion as of Q3 2025, which was up 1289.84% from $262.9 billion recorded in Q3 2024.
  • Over the past 5 years, Universe Pharmaceuticals' Intangibles peaked at $296.8 billion during Q3 2025, and registered a low of $147652.0 during Q1 2024.
  • Over the past 5 years, Universe Pharmaceuticals' median Intangibles value was $222942.5 (recorded in 2022), while the average stood at $70.0 billion.
  • In the last 5 years, Universe Pharmaceuticals' Intangibles plummeted by 9999.99% in 2021 and then soared by 9841148126.84% in 2024.
  • Universe Pharmaceuticals' Intangibles (Quarter) stood at $148584.0 in 2021, then skyrocketed by 84.39% to $273974.0 in 2022, then decreased by 2.5% to $267121.0 in 2023, then skyrocketed by 98411481.27% to $262.9 billion in 2024, then increased by 12.9% to $296.8 billion in 2025.
  • Its last three reported values are $296.8 billion in Q3 2025, $262.9 billion for Q3 2024, and $147652.0 during Q1 2024.